Alliance Global Partners has revised its price target for Quantum-Si (QSI, Financial), now setting it at $3.50, a slight reduction from the previous target of $3.65. Despite this adjustment following the company's first-quarter report, the firm continues to maintain a Buy rating on QSI shares. This indicates ongoing confidence in Quantum-Si's market performance and potential, as assessed by the firm's analysts.
Wall Street Analysts Forecast
Based on the one-year price targets offered by 3 analysts, the average target price for Quantum-Si Inc (QSI, Financial) is $3.33 with a high estimate of $5.50 and a low estimate of $1.00. The average target implies an upside of 125.23% from the current price of $1.48. More detailed estimate data can be found on the Quantum-Si Inc (QSI) Forecast page.
Based on the consensus recommendation from 3 brokerage firms, Quantum-Si Inc's (QSI, Financial) average brokerage recommendation is currently 2.3, indicating "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
QSI Key Business Developments
Release Date: May 15, 2025
- Revenue: $842,000 in Q1 2025, an 84% increase over Q1 2024.
- Gross Profit: $486,000 in Q1 2025.
- Gross Margin: 58% in Q1 2025.
- GAAP Operating Expenses: $25.6 million in Q1 2025, compared to $23.6 million in Q1 2024.
- Adjusted Operating Expenses: $22.9 million in Q1 2025, compared to $21.9 million in Q1 2024.
- Dividend and Interest Income: $2.5 million in Q1 2025, compared to $3.6 million in Q1 2024.
- Cash and Cash Equivalents: $232.6 million as of March 31, 2025.
- Projected Adjusted Operating Expenses for 2025: $103 million or less.
- Projected Total Cash Used for 2025: $95 million or less.
For the complete transcript of the earnings call, please refer to the full earnings call transcript.
Positive Points
- Quantum-Si Inc (QSI, Financial) reported a significant 84% increase in first-quarter revenue compared to the same period in 2024, reaching $842,000.
- The company successfully launched the Platinum Pro system and completed its first customer sales, marking a key milestone in their commercial adoption strategy.
- Quantum-Si Inc (QSI) has expanded its international presence with 23 distribution partners, showing strong performance and interest in international markets.
- The company remains on track to launch its version 4 Sequencing Kit in the third quarter of 2025, which is expected to enhance proteome coverage and amino acid detection.
- Quantum-Si Inc (QSI) has a strong balance sheet with $232.6 million in cash and cash equivalents, providing financial runway into the second half of 2027.
Negative Points
- The company experienced a slowdown in new instrument purchases in the US academic market due to uncertainties related to NIH funding and indirect cost caps.
- First-quarter revenue, although increased, was slightly below the company's expectations.
- Operating expenses increased to $25.6 million in Q1 2025 from $23.6 million in Q1 2024, indicating rising costs.
- The company faces potential impacts from evolving tariffs, which could affect inventory acquisition costs and sales channels outside the United States.
- Quantum-Si Inc (QSI) is unable to provide clear top-line financial guidance due to ongoing uncertainties in the NIH funding environment.
